Pancreatic beta-cell growth and function adapt to changing physiologic demands of the host, but the mechanisms regulating these facultative responses remain unclear. Inadequate adaptation leads to beta-cell failure, and can promote pathogenesis of diabetes mellitus. Physiologic signals like insulin and glucose are potent stimulators of beta-cell proliferation and the signaling pathways downstream of these ligands are well- studied. However, the mechanisms for transducing these cues into genetic changes that culminate in adaptive beta-cell proliferation remain undiscovered. The nuclear factor of activated T-cells (NFAT) proteins are transcription factors whose activation is regulated by intercellular signals, and by calcineurin, a calcium- dependent phosphatase. Recent studies suggest that NFAT proteins in beta-cells are crucial for regulating beta- cell gene expression, proliferation, and function. Demonstration of NFAT activation by beta-cell mitogens and identification of relevant NFAT genetic targets should reveal mechanisms underlying growth regulation of adult pancreatic beta-cells. The goal of this proposal is to elucidate the molecular and in vivo functions of calcineurin-dependent NFAT signaling that control islet development and facultative growth. Calcineurin inactivation in mice results in beta-cell failure, with impaired beta-cell proliferation, decreased insulin production, and reduced beta-cell mass. Mice lacking beta-cell calcineurin function develop overt diabetes. Strikingly, expression of activated NFATc1 in beta-cells lacking calcineurin restores beta-cell growth and prevents diabetes. Experiments in this application will test the hypothesis that NFAT governs expression of genetic targets that control beta-cell cycle, proliferation, and function. This proposal's specific aims are to: (1) Determine if glucose or insulin regulate NFAT function in beta-cells, and test if experimental NFAT activation is sufficient to prevent beta-cell failure (2) Identify target beta-cell genes whose expression is regulated by NFAT, and to reveal mechanisms of transcriptional control (3) Use novel conditional-genetic methods to control calcineurin and NFAT signaling in the embryonic mouse pancreas. These in vivo studies will reveal how NFAT controls gene expression, growth, and differentiation of beta-cells in development. Our genetic, molecular, and cellular analyses of calcineurin and NFAT function will add to the understanding of the mechanisms governing growth and differentiation of beta-cells. Thus, these studies may lead to new diagnostic, prognostic, or therapeutic strategies for a broad range of human diseases, including neuro-endocrine tumors, and diabetes mellitus.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK075919-04S1
Application #
8034896
Study Section
Special Emphasis Panel (ZRG1-EMNR-B (02))
Program Officer
Appel, Michael C
Project Start
2010-03-15
Project End
2011-02-28
Budget Start
2010-03-15
Budget End
2011-02-28
Support Year
4
Fiscal Year
2010
Total Cost
$86,095
Indirect Cost
Name
Stanford University
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Goodyer, William R; Gu, Xueying; Liu, Yinghua et al. (2012) Neonatal ? cell development in mice and humans is regulated by calcineurin/NFAT. Dev Cell 23:21-34
Chen, Hainan; Gu, Xueying; Liu, Yinghua et al. (2011) PDGF signalling controls age-dependent proliferation in pancreatic ?-cells. Nature 478:349-55
McKnight, Kristen D; Wang, Pei; Kim, Seung K (2010) Deconstructing pancreas development to reconstruct human islets from pluripotent stem cells. Cell Stem Cell 6:300-8